Literature DB >> 21902200

Total synthesis of pacidamycin D by Cu(I)-catalyzed oxy enamide formation.

Kazuya Okamoto1, Masahiro Sakagami, Fei Feng, Hiroko Togame, Hiroshi Takemoto, Satoshi Ichikawa, Akira Matsuda.   

Abstract

The first total synthesis of pacidamycin D, which is expected to be a good candidate as an antibacterial agent against P. aeruginosa, is described. The key elements of our approach feature an efficient and stereocontrolled construction of the Z-oxyvinyl iodide and copper-catalyzed cross-coupling with the tetrapeptide carboxamide.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902200     DOI: 10.1021/ol202124b

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics.

Authors:  Daniel Pletzer; Yvonne Braun; Svetlana Dubiley; Corinne Lafon; Thilo Köhler; Malcolm G P Page; Michael Mourez; Konstantin Severinov; Helge Weingart
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

3.  RECENT SYNTHETIC DEVELOPMENTS AND APPLICATIONS OF THE ULLMANN REACTION. A REVIEW.

Authors:  Hao Lin; Dianqing Sun
Journal:  Org Prep Proced Int       Date:  2013       Impact factor: 1.628

Review 4.  Mechanism of action of nucleoside antibacterial natural product antibiotics.

Authors:  Timothy D H Bugg; Rachel V Kerr
Journal:  J Antibiot (Tokyo)       Date:  2019-08-30       Impact factor: 2.649

5.  Total synthesis of the reported structure of ceanothine D via a novel macrocyclization strategy.

Authors:  Jisun Lee; Madeleine M Joullié
Journal:  Chem Sci       Date:  2018-01-31       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.